Advanced search
Publication Cover
The World Journal of Biological Psychiatry Volume 10, 2009 - Issue 4-2
Submit an article Journal homepage
751
Views
44
CrossRef citations to date
0
Altmetric
Case Reports

Repeated intravenous ketamine therapy in a patient with treatment-resistant major depression

Michael Liebrenz Psychiatric University Hospital, Research Group on Substance Use Disorders, Zurich, SwitzerlandCorrespondence[email protected]
,
Rudolf Stohler Psychiatric University Hospital, Research Group on Substance Use Disorders, Zurich, Switzerland
&
Alain Borgeat Department of Anesthesiology, Orthopedic University Hospital Balgrist, Zurich, Switzerland
Pages 640-643 | Received 08 Mar 2007, Published online: 08 Dec 2009

References

  • Beck AT, Beamesderfer A. Assessment of depression: the depression inventory. Mod Probl Pharmacopsychiatry 1974; 7: 151–169
  • Berman RM, Cappiello A, Anand A, et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 2000; 47: 351–354
  • Check E. Depression: Comfortably numb. Nature 2006; 443: 629–631
  • Crown WH, Finkelstein S, Berndt ER, et al. The impact of treatment-resistant depression on health care utilization and costs. J Clin Psychiatry 2002; 63: 963–971
  • Delgado PL. Depression: the case for a monoamine deficiency. J Clin Psychiatry 2000; 61: 4–6
  • Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56–62
  • Hirschfeld RM. History and evolution of the monoamine hypothesis of depression. J Clin Psychiatry 2000; 61(Suppl 6)4–6
  • Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 617–627
  • Manji HK, Quiroz JA, Sporn J, et al. Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression. Biol Psychiatry 2003; 53: 707–742
  • Papakostas GI. Dopaminergic-based pharmacotherapies for depression. Eur Neuropsychopharmacol 2006; 16: 391–402
  • Petrakis IL, Limoncelli D, Gueorguieva R, et al. Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism. Am J Psychiatry 2004; 161: 1776–1782
  • Spitzer RL, Williams JB, Gibbon M, First MB. The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry 1992; 49: 624–629
  • Zarate CA, Payne LJ, Quiroz J, et al. An open-label trial of riluzole in patients with treatment-resistant major depression. Am J Psychiatry 2004; 161: 171–174
  • Zarate CA, Jr, Singh JB, Carlson PJ, et al. A randomised trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 2006; 63: 856–864

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.